Virtual World-Based Cardiac Rehabilitation
VWCR
1 other identifier
interventional
2,881
1 country
1
Brief Summary
The proposed trial is a multiphase, multicenter, non-inferiority, hybrid type 1 effectiveness, randomized controlled trial to test an innovative virtual world-based cardiac rehabilitation (CR) program, "Destination Cardiac Rehab". The primary objectives of this study are to assess the efficacy and adherence of "Destination Cardiac Rehab" compared to traditional center-based CR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 7, 2023
CompletedFirst Submitted
Initial submission to the registry
May 5, 2023
CompletedFirst Posted
Study publicly available on registry
June 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2024
CompletedFebruary 27, 2026
February 1, 2026
11 months
May 5, 2023
February 24, 2026
Conditions
Outcome Measures
Primary Outcomes (10)
Life's Essential 8 component: Self-reported healthy diet
Changes from baseline in healthy diet using the Mediterranean Eating Patterns for Americans (MEPA), a 16-item questionnaire evaluating accordance with a Mediterranean-like diet pattern
Baseline, 3 months, and 6 months post-randomization
Life's Essential 8 component: Self-reported physical activity
Changes from baseline in physical activity using the International Physical Activity Questionnaire (IPAQ), a 12-item questionnaire classifying physical activity as "low," "moderate," or "high" intensity physical activity (minutes/day) over the prior week
Baseline, 3 months, and 6 months post-randomization
Life's Essential 8 component: Self-Reported smoking status
Changes from baseline in smoking status using the National Health and Nutrition Examination Survey-Smoking-Cigarette Use Questionnaire (NHANES-SMQ), evaluating current and past smoking habits
Baseline, 3 months, and 6 months post-randomization
Life's Essential 8 component: Sleep Quality
Changes from baseline in sleep quality (number of hours of sleep nightly) using the Pittsburg Sleep Quality Index (PSQI).
Baseline, 3 months, and 6 months post-randomization
Life's Essential 8 component: Body Mass Index (BMI)
Changes from baseline in BMI as calculated with weight (kg) and height (m), reported as kg/m\^2
Baseline, 3 months, and 6 months post-randomization
Life's Essential 8 component: Cholesterol
Changes from baseline in Non-HDL Cholesterol levels reported as mg/dL
Baseline, 3 months, and 6 months post-randomization
Life's Essential 8 component: Blood Glucose
Changes from baseline in Hemoglobin A1c (percent) and fasting blood glucose (mg/dL)
Baseline, 3 months, and 6 months post-randomization
Life's Essential 8 component: Blood Pressure
Changes from baseline in systolic and diastolic blood pressure measurements; average of three sitting readings in mmHg
Baseline, 3 months, and 6 months post-randomization
Life's Essential 8 composite score: Cardiovascular health
Changes from baseline in Life's Essential 8 score. Life's Essential 8 composite score is determined as a composite of all components by calculating an unweighted average score on a scale of 0 to 100 points. An overall cardiovascular health score (Life's Essential 8 score) will be considered high (80 to 100 points), moderate (50 to 79 points) or low for (0 to 49 points).
Baseline, 3 months, and 6 months post-randomization
Number of sessions attended by participants
Optimal adherence defined as completion of 70% or more of weekly visits (in-person or virtual). Attendance measured by CR staff for control group, and by VWCR web administrators, Exercise Physiologists, and Nurse Coaches in the VWCR arm.
Baseline through 12-week program
Secondary Outcomes (10)
MACE (Major Adverse Cardiovascular Events) 3 months post-randomization
3 months and 6 months post-randomization
Exercise Sessions
Baseline through 12-week (36 session) cardiac rehabilitation program
Functional Capacity
Baseline, 3 months, and 6 months post-randomization
Health-related quality of life
Baseline, 3 months, and 6 months post-randomization
Physical Activity Self-efficacy
Baseline, 3 months, and 6 months post-randomization
- +5 more secondary outcomes
Study Arms (2)
Center-Based Cardiac Rehab (CBCR)
ACTIVE COMPARATORStandard of care for participants' center-based cardiac rehabilitation program. Traditional 12-week, in-person program.
Virtual World-Based Cardiac Rehab (VWCR)
EXPERIMENTALTelehealth delivery of cardiac rehabilitation via Second Life virtual world platform. 12-week, home-based program.
Interventions
12-week virtual world technology-based program via Second Life platform. Weekly virtual visits with nurse coach and exercise physiologist, weekly education sessions, and social support group discussions within the virtual world environment.
Traditional 12-week in-person cardiac rehabilitation program; standard of care at participant's cardiac rehabilitation facility
Eligibility Criteria
You may qualify if:
- Indication for CR according to Centers for Medicare \& Medicaid Services (CMS) guidelines: Myocardial infarction within the preceding 12 months; Coronary artery bypass surgery; Current stable angina (chest pain); Heart valve repair or replacement; Percutaneous transluminal coronary angioplasty (PTCA) or coronary stenting; Heart or heart-lung transplant; Stable chronic heart failure
- Aged ≥18 years
- Basic Internet navigation skills
- Active email address
You may not qualify if:
- High risk patients according to the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) risk stratification (e.g., sudden cardiac arrest survivor)
- Receiving continuous inotropic support
- Presence of a mechanical circulatory support device
- Decompensated heart failure
- Symptomatic valvular heart disease
- Uncontrolled angina
- Presence of hemodynamically unstable dysrhythmias (e.g., ventricular tachycardia) given safety concern of unsupervised exercise20
- Pregnant (due to associated hormonal and weight changes)
- Non-English-speaking
- Visual/hearing impairment or mental disability that would preclude independent use of the VW platform
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
- Johns Hopkins Universitycollaborator
- University of California, Irvinecollaborator
- University of Mississippi Medical Centercollaborator
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55905, United States
Related Publications (1)
Brewer LC, Abraham H, Clark D 3rd, Echols M, Hall M, Hodgman K, Kaihoi B, Kopecky S, Krogman A, Leth S, Malik S, Marsteller J, Mathews L, Scales R, Schulte P, Shultz A, Taylor B, Thomas R, Wong N, Olson T. Efficacy and Adherence Rates of a Novel Community-Informed Virtual World-Based Cardiac Rehabilitation Program: Protocol for the Destination Cardiac Rehab Randomized Controlled Trial. J Am Heart Assoc. 2023 Dec 5;12(23):e030883. doi: 10.1161/JAHA.123.030883. Epub 2023 Nov 28.
PMID: 38014699DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
LaPrincess Brewer, M.D., M.P.H.
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
May 5, 2023
First Posted
June 9, 2023
Study Start
March 7, 2023
Primary Completion
January 31, 2024
Study Completion
January 31, 2024
Last Updated
February 27, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share